pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

Trump administration threatens fines for over 500 hospitals that fail to disclose pricing

Jun 9, 2026·read at STAT ↗RegulatoryNegative

The Trump administration has warned more than 500 hospitals that they are not providing the public with basic pricing information, the Associated Press reported.

Hospitals that fail to create a plan to post clear pricing data could be fined as much as $2 million each year, according to the letters sent since April.

The enforcement effort builds on a 2019 executive order on price transparency, and officials said President Donald Trump intends to increase oversight, meaning additional hospitals may receive similar warnings.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Trump administration warns more than 500 hospitals to provide more price information or face fines”

read at STAT ↗
913 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of Texas MD Anderson Cancer Center
topics
HematologyOncology

related stories

  • May 13Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practiceonclive
  • May 13FDA Approves Decitabine/Cedazuridine Plus Venetoclax in Newly Diagnosed AMLonclive
  • May 13Dr Dinardo on the FDA Approval of Decitabine/Cedazuridine Plus Venetoclax in AMLonclive
  • May 10Five Under 5: Top Oncology Videos for the Week of 5/3onclive
  • May 8UT MD Anderson Shares Latest Research Breakthroughsonclive